Researchers in the Lanske Laboratory at Harvard School of Dental Medicine (HSDM) in collaboration with the Rosen Laboratory at Maine Medical Center have been studying the function of Parathyroid hormone (PTH) beyond its well-known role in maintaining calcium homeostasis in the body. PTH has been approved for treatment of osteoporosis in humans to induce bone formation. Their recent finding published in Cell Metabolism Read more about Lanske Lab Research Finding Could Influence Treatment of Osteoporosis and Other Diseases

A recent research finding published in Stem Cell Reports could potentially lead to therapies that address craniofacial malformations in children. Craniofacial malformations are deformities that affect a child’s head and facial bones—disorders such as cleft palate, or craniosynostosis that are present at birth.

Read more about Intini Lab Research Leads to Collaboration with Boston Children's Hospital Surgeons on Potential Treatments for Craniofacial Malformations

Today, the HSDM community gathered to celebrate the newest Dean's Scholars. Dean Bruce Donoff presented the awards at a special tea held in the Research and Education Building. The Dean’s Scholars program provides dedicated time and funding for outstanding individuals to develop and refine the skills necessary for future success in academics and research. This years’ award recipients are:

Shek Man (Jacky) Chim research fellow in Developmental Biology and member of the Rosen Lab. Chim received an award for his project on the interplay of BMP and activin Read more about 2016-2017 Dean’s Scholars Announced

By Ellen Garnett
Dr. Bernard Friedland, assistant professor in Oral Medicine, Infection and Immunity, recently received a National Institutes of Health (NIH) Fogarty International Center Award for his research project, “Development Initiative for Ethical Review and Oversight of Health Research Involving Human Subjects in Rwanda.”

Harvard School of Dental Medicine (HSDM) was one of four Read more about HSDM to Lead Program in Rwanda on Ethics Training in Health Research

As we age, every stumble or fall comes with a risk—a risk that is even greater for those ten million people in the U.S. who have osteoporosis, a skeletal disease characterized by low bone mass, poor bone quality and fractures. Each year, 1.5 million bone fractures are attributed to osteoporosis, including 350,000 hip fractures. But hip or other fractures in older and osteoporotic patients do not heal easily and this often leads to significant impairments in daily life, and even death.

Dr. Roland Baron, professor and chair of Read more about New Study by HSDM Researchers May Have Implications for Treating Osteoporosis

William Addison, Xuchen (Aimee) Duan, and Yi Fan, have been named the 2015-2016 HSDM Dean’s Scholars. The Dean’s Scholars Program provides postdocs with funding during the early stages of their academic career. This year’s Scholars will focus on the following areas of research:

Read more about 2015-2016 HSDM Dean’s Scholars Announced

Dr. Malcolm Whitman, PHD87, HSDM professor of developmental biology, and Tracy Keller, SM87, PHD96, an instructor in the Department of Developmental Biology, have identified a chemical compound based on an active ingredient in the root of the blue evergreen hydrangea (Dichroa febrifuga), that could lead to treatment of chronic fibrotic and autoimmune diseases. The root has been used in traditional Chinese medicine for centuries. Whitman and Keller identified the mechanism of action, halofuginone (HF), found within the root.

Now, Allied-Bristol Life Sciences (ABLS) a Read more about Professor Malcolm Whitman Gets Backing of Allied-Bristol Life Sciences (ABLS)